心脏病学学报 SCIE

期刊简介预计审稿时间： 12周，或约稿

Acta Cardiologica Sinica welcomes all the papers in the fields related to cardiovascular medicine including basic research, vascular biology, clinical pharmacology, clinical trial, critical care medicine, coronary artery disease, interventional cardiology, arrythmia and electrophysiology, atherosclerosis, hypertension, cardiomyopathy and heart failure, valvular and structure cardiac disease, pediatric cardiology, cardiovascular surgery, and so on. We received papers from more than 20 countries and areas of the world. Currently, 40% of the papers were submitted to Acta Cardiologica Sinica from Taiwan, 20% from China, and 20% from the other countries and areas in the world. The acceptance rate for publication was around 50% in general.

《心脏病学报》欢迎所有与心血管医学相关的论文投稿，包括基础研究、血管生物学、临床药理学、临床试验、重症医学、冠心病、介入心脏病学、心律失常与电生理、动脉粥样硬化、高血压、心肌病与心力衰竭、心脏瓣膜与结构疾病、小儿心脏病学、心血管外科等。本期刊收到来自全球20多个国家和地区的论文。目前，《心脏病学报》投稿论文中，台湾占40%，中国大陆占20%，其他国家占20%，一般投稿率在50%左右。

《Acta Cardiologica Sinica》(心脏病学学报)编辑部通讯方式为TAIWAN SOC CARDIOLOGY, 7F NO 27 MIN-CHUAN W RD, TAIPEI, TAIWAN, 104。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。